Hypercholesterolemia In Men Research Articles

Influence of multimorbidity on the risk of events in men with chronic coronary artery disease after myocardial infarction and percutaneous coronary intervention

Aim. To study the effect of multimorbidity on the risk of cardiovascular events (CVEs) in men with chronic coronary artery disease (CAD) after myocardial infarction (MI) and percutaneous coronary intervention (PCI).Material and methods. A total of 101 men with chronic CAD after MI and PCI were included in the study (mean age 60,5±6,1 years). Of these, taking into account the non-inclusion criteria and consent to examination, 2 following groups were formed: first (n=39) — men without CVEs; 2nd (n=39) — men with CVEs. In both groups, we studied the detection rate of grade I hypertension (HTN), class I obesity, hypercholesterolemia (HCE), and type 2 diabetes (T2D). The influence of HTN, obesity, HCE, and T2D on the risk of cardiovascular events was analyzed based on the calculation of contingency tables and Pearson's χ2, as well as odds ratios (OR) with 95,0% confidence intervals (CI). The follow-up period for patients averaged 3,6±0,5 years.Results. In men of group 2, compared with group 1 patients, grade I HTN, class I obesity, HCE were diagnosed more often in 1,3 (p=0,044), 1,4 (p=0,047), 1,2 (p=0,059) times, respectively. An increase in the risk of CVEs in men with chronic CAD, who underwent MI and PCI was associated with the detection of grade I HTN, class I obesity, HCE — OR 2,44 (CI: 1,88-6,75), OR 1,78 (CI: 1,56-4,62), OR 1,37 (CI: 1,11-4,17), respectively.Conclusion. Thus, the detection rate of grade I HTN, class I obesity and HCE in men with chronic CAD and CVEs at long-term follow-up after MI and PCI was significantly higher compared to patients with chronic CAD without CVEs after PCI. At the same time, the detection of grade I HTN, class I obesity and HCE were associated with an increased risk of cardiovascular events.

Invitro and Invivo Analysis of Human Milk Lactic Acid Bacteria Isolates for Their Anti-hypercholesterolemia Actions.

The aim of this study was to evaluate the cholesterol lowering ability of Lactic Acid Bacteria (LAB) isolated from human breast milk under in vitro and in vivo conditions. Six LAB isolates namely Lacticaseibacillus casei 1A, Lactobacillus gasseri 5A, Enterococcus faecium 2C, Limosilactobacillus fermentum 3D, Pediococcus acidilactici 1C, and Lactiplantibacillus plantarum 7A, were examined for their bile resistance, bile salt hydrolase activity, cholesterol assimilation and viability in cholesterol rich; DeMan Rogosa and Sharpe broth, simulated gastric, small and upper intestinal conditions. During in vivo experiments, two putative LAB isolates were orally gavage to BALB/c mice, fed with normal basal and cholesterol rich (HCD) diets, daily for a period of 4 weeks. Blood serum analysis including total serum cholesterol, triglycerides, high-density and low-density lipoprotein (LDL) cholesterol levels and total fecal LAB counts of the animals were determined. The isolates in study showed bile resistance and bile salt hydrolysis activity, while significant differences (P < 0.05) were seen in their cholesterol assimilation ability. L. gasseri 5A (195.67%) and L. plantarum 7A (193.78%) displayed highest cholesterol removal percentages, respectively. Animals in HCD, fed with L. gasseri 5A and L. plantarum 7A showed decreased levels of total cholesterol and LDL, compared to the control groups. In HCD group liver weight was increased, while fecal LAB counts were decreased. No changes were observed in behavior or body weight in all experimental groups. In conclusion, L. gasseri 5A and L. plantarum 7A isolated from human breast milk demonstrates significant hypocholesterolaemic actions in vitro and in vivo and might be considered a promising candidates for preventing hypercholesterolemia in man and animals.

Prognostic value of diagnostic criteria for familial hypercholesterolemia in men and women with dyslipidemia

Aim. To analyze the prognostic value of the Dutch Lipid Clinic Network (DLCN) and Simon Broome Register (SBR) screening criteria for familial hypercholesterolemia (FH) in men and women with dyslipidemia.Material and methods. The study included 1233 patients with dyslipidemia.Biomaterial samples from 421 patients were studied using Next Generation Sequencing (NGS) to identify FH-associated genes. Statistical analysis was carried out using the StatTech v program. 3.1.6 (OOO Stattekh, Russia).Results. The most significant factors for predicting the FH in men are the level of low-density lipoprotein cholesterol (LDL-C) (1,77 times), positive family history for coronary artery disease (CAD) (6,26 times), multivessel coronary artery disease (4,05 times); in women before menopause — LDL-C (1,77 times per 1 mmol/l) and/or family history of coronary artery disease (3,31 times), in menopausal women — total cholesterol level (1,79 times per 1 mmol/l), coronary artery disease (6,52 times) and/or family history of stroke (6,04 times), xanthomas (4,24 times). Acute myocardial infarction and/or coronary stenting, arcus senilis, extracranial artery atherosclerosis did not prove to be prognostically significant for FH diagnosis.Conclusion. Diagnostic criteria for potential FH vary among patient populations. Its diagnostic significance depends on sex, and in women, reproductive status.

Changes in the management of hypertension, diabetes mellitus, and hypercholesterolemia in Korean adults before and during the COVID-19 pandemic: data from the 2010-2020 Korea National Health and Nutrition Examination Survey.

This study aimed to analyze the changes in chronic disease management indicators, including hypertension, diabetes mellitus, and hypercholesteremia, from 2010-2020 and before (2019) and during (2020) the coronavirus disease 2019 (COVID-19) pandemic. This study included 58,504 individuals aged ≥30 years who participated in the Korea National Health and Nutrition Examination Survey 2010-2020. Trends in the prevalence, awareness, treatment, and control of chronic diseases and the difference in those between before and during the COVID-19 pandemic were analyzed using the SAS program PROC SURVEYREG. From 2010-2020, the awareness, treatment, and control in adults aged ≥30 years for hypertension and hypercholesterolemia continuously improved, whereas no significant change in the management indicators of diabetes mellitus was observed. The prevalence of hypertension, diabetes mellitus, and hypercholesterolemia in men increased from before to during the COVID- 19 pandemic. However, there was no significant change in the management indicators of hypertension and diabetes mellitus in men and women, and the awareness, treatment, and control rates for hypercholesterolemia increased by 5.5%p, 6.9%p, and 4.1%p respectively. In 2020, the first year of the COVID-19 pandemic, the prevalence of hypertension, diabetes mellitus, and hypercholesterolemia increased, but the management indicators of the chronic diseases did not significantly deteriorate. Considering the ongoing COVID-19 pandemic, it is necessary to monitor changes in chronic disease management indicators and to develop efficient and accessible chronic disease prevention and management programs.

Association between visceral fat accumulation and decline in the estimated glomerular filtration rate based on cystatin C in the Japanese urban population: the KOBE study.

Although metabolic syndrome, including visceral fat accumulation, causes kidney and cardiovascular diseases, the impact of visceral fat accumulation on mild decreased renal function remains unclear. This study examines the association between visceral fat area (VFA) measured by bioimpedance methods and the estimated glomerular filtration rate based on serum cystatin C (eGFRcys) in the Japanese urban population. This community-based cross-sectional study enrolled 952 individuals (287 men, 665 women) who participated in the second follow-up survey of the Kobe Orthopedic and Biomedical Epidemiological (KOBE) study. We compared the multivariate-adjusted means of eGFRcys among VFA quartile groups by gender using the analysis of covariance. Models were adjusted for age, high blood pressure, hypercholesterolemia, glucose intolerance, smoking, and alcohol use, and further adjusted for body mass index (BMI). The highest VFA quartile group had lower eGFRcys than the lowest VFA quartile group after adjusted for cardiometabolic risk factors, except for BMI (93.1 [95% confidence interval (CI), 90.1-96.2] vs. 82.1 [95% CI, 79.1-85.0] in men and 95.8 [95% CI, 94.1-97.5] vs. 89.4 [95% CI, 87.8-90.9] in women). Moreover, further adjustment for BMI revealed a similar result in men (93.5 [95% CI, 89.8-97.2] vs. 81.6 [95% CI, 77.9-85.3]), while no significant association was found in women. This study suggests a significant association between increased VFA levels and lower eGFRcys levels independent of cardiometabolic risk factors, such as glucose intolerance and hypercholesterolemia in men and women, as well as independent of BMI in men.

Associations of adipokines and metabolic hormones with low-density lipoprotein hypercholesterolemia in men and women under 45 years of age.

Aim To study the adipokine profile in young people with hypercholesterolemia and low-density lipoproteins (LDL) and to evaluate the relationship between concentrations of LDL cholesterol (LDL-C) and metabolic hormones in men and women younger than 45 years.Material and methods This study included 304 subjects (group 1, 56 men with LDL-C concentration &lt;2.1 mmol/l; group 2, 87 men with LDL-C concentration ≥4.2 mmol/l; group 3, 90 women with LDL-C concentration &lt;2.1 mmol/l; and group 4, 71 women with LDL-C concentration ≥4.2 mmol/l). Serum concentrations of total cholesterol (C), triglycerides (TG), high-density lipoprotein C, and glucose were measured by an enzymatic assay with ThermoFisher Scientific kits and a KonelabPrime 30i biochemical analyzer. LDL-C was calculated using the Friedewald's formula. Concentrations of amylin, C-peptide, ghrelin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 (GLP-1), glucagon, interleukin 6, insulin, leptin, monocyte chemotactic protein 1 (MCP-1), pancreatic polypeptide (PP), peptide YY (PYY), tumor necrosis factor alpha (TNF-α), adiponectin, adipsin, lipocalin-2, plasminogen activator inhibitor 1 (PAI-1), and resistin were measured by multiplex analysis (Human Metabolic Hormone V3 and Human Adipokine Panel 1 panels).Results The groups differed in traditional cardiometabolic risk factors. In the male and female patient groups with LDL-C ≥4.2 mmol/l, the prevalence of impaired fasting glucose, incidence of insulin resistance, TG, and TC were higher than in subjects with LDL-C &lt;2.1 mmol/l. The odds for the presence of LDL hypercholesterolemia (LDL-C ≥4.2 mmol/l) were significantly associated with increased concentrations of C-peptide and lipocalin-2 in men and with increased concentrations of lipocalin-2 and decreased concentrations of GLP-1 in women (р&lt;0.05).Conclusion Increased concentrations of LDL-C in young people were associated with changes in the adipokine profile and with the presence of metabolic syndrome components. These results were confirmed by changes in blood concentrations of metabolic markers that characterize disorders of metabolic processes.

Comparison of anthropometric and body composition indices in the identification of metabolic risk factors

Whether anthropometric or body composition indices are better indicators of metabolic risk remains unclear. The objectives of this study were to compare the association of metabolic risk factors with anthropometric and body composition indices and to identify the better indicators for risk factors in a large-scale Korean population. In this cross-sectional study, the associations of body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR) as anthropometric indices and trunk fat mass (TFM), percent trunk fat mass (%TFM), whole-body total fat mass (WBTFM), and percent whole-body total fat mass (%WBTFM) as body composition indices with metabolic risk factors were compared by complex-samples multiple logistic regression models based on complex-sample survey data. In men, WHtR, BMI, and TFM were similarly associated with hypertension. Diabetes, hyperlipidemia, and hypo-high-density lipoprotein (HDL) cholesterolemia tended to be more strongly associated with WHtR and WC than body composition indices. Hypertriglyceridemia and hypercholesterolemia were more strongly associated with WHtR and %TFM than other indices. In women, hypertension tended to be more strongly associated with WHtR than other indices. TFM, %TFM, and WHtR were similarly associated with hyperlipidemia. Diabetes and hypo-HDL cholesterolemia were more strongly associated with WHtR and WC than body composition indices. Hypertriglyceridemia and hypercholesterolemia were more strongly associated with WHtR and %TFM than other indices. Among six metabolic risk factors, the validity and utility of the anthropometric indices in identifying risk factors tended to be similar to or better than those of the body composition indices, except for hypertension and hypercholesterolemia in men and hyperlipidemia and hypercholesterolemia in women.

Association between physical activity and cardiovascular risk factors: Dose and sex matter

Abstract Objective We studied the association between different levels of physical activity (PA) and major cardiovascular disease (CVD) risk factors in adult people, as well as sex-specific differences. Methods Medical data from a large Spanish cohort of workers (aged 18-64 years) were prospectively obtained during a five-year period. Participants were categorized attending to their self-reported PA levels as inactive (performing neither moderate nor vigorous-intensity PA), or either regularly or insufficiently active (meeting or not, respectively, international recommendations of PA [≥ 150 or ≥ 75 min/week of moderate or vigorous-intensity PA, respectively, or a combination thereof]), and risk of diabetes, hypercholesterolemia, hypertension, and obesity was assessed. Results Data from 527,662 participants (32% women) were used for analysis. 63.5, 12.3, and 24.2 % of the participants were inactive, insufficiently active, and regularly active, respectively. A significantly lower likelihood of all CVD risk factors was found in both regularly active (by 42 to 10%) and – although less remarkable – insufficiently active individuals (by 30 to 9%) vs their inactive referents. Although these results were overall corroborated in sex-specific analyses, a PA dose-dependent association was not observed for hypercholesterolemia in men and PA – whether insufficient or regular – conferred no significant protective effect against obesity in women. Conclusions Our findings suggest that PA reduces the odds of major CVD risk factors in a dose-response manner but there are some sex-specific differences.

Dietary sodium:potassium ratio and CVD risk factors among Japanese adults: a retrospective cross-sectional study of pooled data from the National Health and Nutrition Survey, 2003-2017.

Few studies have reported associations between the Na:K ratio and risk factors related to CVD among the general population in Asian countries. This study aimed to investigate the dietary Na:K ratio association with CVD risk factors among Japanese adults. This retrospective cross-sectional study included 48800 Japanese participants (19386 men and 29414 women) aged ≥20 years, registered in the 2003-2017 National Health and Nutrition Survey. Multivariate OR and 95 % CI for risk of hypertension, high glycated HbA1c levels, hypercholesterolaemia, low serum levels of HDL-cholesterol and high non-HDL-cholesterol levels according to the Na:K ratio were estimated using logistic regression models. Dietary Na:K ratio decreased for both men and women from 2003 to 2017. Higher Na:K ratio and higher hypertension prevalence were observed (multivariate OR (fifth v. first quintiles) 1·27, 95 % CI 1·15, 1·40; Pfor trend < 0·001 for men and 1·12, 95 % CI 1·01, 1·23; Pfor trend = 0·007 for women). Higher Na:K ratio was associated with higher prevalence of high HbA1c levels in men (multivariate OR 1·56, 95 % CI 1·24, 1·96). Prevalence of low HDL-cholesterol levels was increased with higher Na:K ratio (Pfor trend =0·002 for men and <0·001 for women). No significant associations were found between Na:K ratio and hypercholesterolaemia in men or high non-HDL-cholesterol levels in both men and women. Our findings suggest that dietary Na:K ratio is associated with several CVD risk factors among Japanese adults.

Hypercholesterolaemia increases the risk of high‑turnover osteoporosis in men.

As the incidence of osteoporosis (OP) and hypercholesterolaemia in men has increased, male OP has drawn more attention from clinicians worldwide. The present study sought to investigate the effects of cholesterol on male bone. Between July 2015 and October 2015, 216 men (aged ≥18 years) were recruited for this cross-sectional study. To test our clinical hypothesis, we designed two male animal models: Exogenous hypercholesterolaemia induced by a high-cholesterol diet (HCD) and endogenous hypercholesterolaemia induced by apolipoprotein E (ApoE) knockout. Finally, the direct effects of cholesterol on osteoblasts were observed in cell experiments. In our clinical studies, men with hypercholesterolaemia displayed a lower bone mineral density (BMD) and increased beta collagen cross-linking (beta-CTX) and type I anterior collagen amino terminal peptide (PINP) levels compared to those of the control subjects. Serum cholesterol levels were a significant independent predictor of BMD, beta-CTX and PINP and were negatively correlated with BMD and positively correlated with beta-CTX and PINP levels. Our animal experimental results validated our clinical results, as they also indicated that hypercholesterolaemia damages bone microstructure and reduces bone strength. Cholesterol directly increased osteoblast functional gene expression in vitro. Hypercholesterolaemia increases the risk of high-turnover osteoporosis in men at least in part by excessively promoting the activity of the remodelling pathway. In addition, hypercholesterolaemia damages the bone microstructure, resulting in osteopenia or OP and reduced bone strength, leading to a higher risk of fracture in men. We emphasize the importance of preventing and treating hypercholesterolaemia as well as monitoring bone metabolic markers and BMD in men with hypercholesterolemia for the effective prevention of bone loss and subsequent fracture. In addition, our findings provide a theoretical basis for the development of treatments for high cholesterol-induced osteoporosis in men.

Association of Resistance Exercise With the Incidence of Hypercholesterolemia in Men

ObjectiveTo examine the associations of resistance exercise, independent of and combined with aerobic exercise, with the risk of development of hypercholesterolemia in men. Patients and MethodsThis study used data from the Aerobics Center Longitudinal Study, which is a cohort examining the associations of clinical and lifestyle factors with the development of chronic diseases and mortality. Participants received extensive preventive medical examinations at the Cooper Clinic in Dallas, Texas, between January 1, 1987, and December 31, 2006. A total of 7317 men aged 18 to 83 years (mean age, 46 years) without hypercholesterolemia at baseline were included. Frequency (times per week) and total amount (min/wk) of resistance and aerobic exercise were determined by self-report. Hypercholesterolemia was defined as a total cholesterol level of 240 mg/dL or higher or physician diagnosis. ResultsDuring a median (interquartile range) follow-up of 4 (2 to 7) years, hypercholesterolemia developed in 1430 of the 7317 men (20%). Individuals meeting the resistance exercise guidelines (≥2 d/wk) had a 13% lower risk of development of hypercholesterolemia (hazard ratio [HR], 0.87; 95% CI, 0.76-0.99; P=.04) after adjustment for general characteristics, lifestyle factors, and aerobic exercise. In addition, less than 1 h/wk and 2 sessions per week of resistance exercise were associated with 32% and 31% lower risks of hypercholesterolemia (HR, 0.68; 95% CI, 0.54-0.86; P=.001; and HR, 0.69; 95% CI, 0.54-0.88; P=.003), respectively, compared with no resistance exercise. Higher levels of resistance exercise did not provide benefits. Meeting both resistance and aerobic exercise guidelines (≥500 metabolic equivalent task min/wk) lowered the risk of development of hypercholesterolemia by 21% (HR, 0.79; 95% CI, 0.68-0.91; P=.002). compared with meeting none of the guidelines. ConclusionCompared with no resistance exercise, less than 1 h/wk of resistance exercise, independent of aerobic exercise, is associated with a significantly lower risk of development of hypercholesterolemia in men (P=.001). However, the lowest risk of hypercholesterolemia was found at 58 min/wk of resistance exercise. This finding suggests that resistance exercise should be encouraged to prevent hypercholesterolemia in men. However, future studies with a more rigorous analysis including major potential confounders (eg, diet, medications) are warranted.

PP.11.14] PREVALENCE OF CARDIOVASCULAR DISEASE RISK FACTORS AMONG VISITORS OF HEALTH CENTERS IN 2010–2015

Objective: The aim of our study was to assess the prevalence of hypercholesterolemia (HH), obesity, hypertension, high-normal blood pressure and isolated systolic hypertension (ISH) as cardiovascular disease risk factors among visitors of Health Centers (HC) in Russia and its regions. Design and method: The data of 435299 men and women aged 25–64 years who visited HC in more than 20 regions of Russia from 2010 to 2015 were analyzed. Results: The prevalence of HH in men and women was 30.4% and 25.9% consecutively, obesity - 15.7% and 21.6%, hypertension - 19.3% and 15.1%. The prevalence of high-normal blood pressure among visitors of HC aged 20–85 was 17.7% and 14.4% in men and women respectively (total prevalence 15.9%). Prevalence of ISH was 6.5% in men, 8.3% in women (total prevalence 7.5%). Stage 1 ISH was observed in 16.6% of women and 16.7% of men (16.7% of sample), the prevalence of stage 2 was 5.9% in both men and women (5.9% of sample), stage 3 ISH was in 1.7% of men and 1.8% of women (1.8% of sample). HH and obesity are found to be more common in women, hypertension - in men. Standardized evaluation of obesity prevalence varies depending on the region from 10.3% in Kurgan region to 48.5% in Belgorod region, hypertension - from 12.4% in Kurgan region to 55.0% in Bryansk region, HH - from 24.1% in Moscow to 60.9% in Saratov region. According to the standardized evaluation the prevalence of obesity, HH and hypertension in Moscow, Kurgan region and Chuvash republic is lower than in average in Russia. Obesity in Belgorod region (48.5%), hypertension in Bryansk region (55.0%) and HH in Saratov region (60.9%) are two times more prevalent than in average in Russia. Conclusions: Analysis of the cardiovascular risk factors in visitors of the HC in Russia revealed a favorable situation in Moscow, Kurgan region and the Chuvash Republic. However, in most regions, the prevalence of obesity, hypertension and HH is quite high, suggesting the need to enhance measures for the prevention of cardiovascular diseases, changing lifestyle and food habits, correction of therapy.

Association Of Resistance Exercise With The Incidence Of Hypercholesterolemia In Men

Hypercholesterolemia is a significant risk factor for cardiovascular disease. Although the beneficial effects of aerobic exercise (AE) are well-documented, evidence for the effects of resistance exercise (RE) on the development of hypercholesterolemia is still scarce. PURPOSE: To examine the associations of RE, independent of and combined with AE, with the risk of developing hypercholesterolemia in men. METHODS: Men, aged 18-83 years (mean age 46), who received comprehensive preventive examinations at the Cooper Clinic in Dallas, Texas, were included in this study. Baseline RE, AE, and meeting the 2008 US Physical Activity Guidelines (RE ≥2 days/week; AE ≥500 MET-minutes/week) were determined by self-reported frequency and minutes of exercise. Hypercholesterolemia was defined as total cholesterol of ≥240 mg/dL or physician-diagnosed hypercholesterolemia during follow-up examinations. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards regression. RESULTS: Among 7,317 participants, 1,430 men (20%) developed hypercholesterolemia during a median follow-up of 4 years. Individuals meeting the RE guidelines had a 13% lower risk of developing hypercholesterolemia (HR 0.87; 95% CI 0.77 to 0.996) after adjustment for potential confounders and AE. In addition, after full adjustment, less than 1 hour/week and 2 sessions/week of RE were associated with 32% and 31% lower risks of hypercholesterolemia (HR 0.68; 95% CI 0.54 to 0.86 and HR 0.69; 95% CI 0.54 to 0.88), respectively, compared to no RE. Higher levels of RE did not show additional benefits. Further, meeting guidelines for both RE and AE lowered the risk of hypercholesterolemia by 21% (HR 0.79; 95% CI 0.68 to 0.92), compared to meeting neither of the guidelines. CONCLUSIONS: Even less than 1 hour/week and 2 sessions/week of RE, independent of AE, were associated with significantly lower risk of developing hypercholesterolemia in men. This finding suggests that RE should be added to habitual physical activity to prevent hypercholesterolemia.

High-risk drinking is associated with dyslipidemia in a different way, based on the 2010–2012 KNHANES

BackgroundThe Alcohol Use Disorders Identification Test (AUDIT) questionnaire is a simple and useful method for the early detection of hazardous and harmful drinking. In this study, we examined the association between alcohol drinking pattern and dyslipidemia in Korean adults. MethodsThis cross-sectional study included 14,308 participants who took part in the 2010–2012 Korean National Health and Nutrition Examination Survey. We categorized alcohol drinking patterns into three groups. We classified dyslipidemia into hypercholesterolemia, hypertriglyceridemia, hypo-HDL-cholesterolemia, hyper-LDL-cholesterolemia, and hyper-non-HDL-cholesterolemia. ResultsOf those who participated, 25.1% of men and 4.8% of women were high-risk drinkers. Compared with the low-risk group, Odd Ratios for hypercholesterolemia and hypertriglyceridemia in the high-risk group were 1.198 (1.001–1.434) and 1.979 (1.622–2.413) for men. Odd Ratios for hypo-HDL-cholesterolemia in the high-risk group was 0.351 (0.279–0.441) in men and 0.413 (0.291–0.586) in women. Compared with the low-risk participants, the high-risk group was associated with higher prevalence and increased risk for hyper-LDL-cholesterolemia in both sexes (1.541 [1.467–1.913] for men and 1.631 [1.034–2.575] for women). ConclusionsHigh-risk drinking was associated with higher risk for hypertriglyceridemia and hyper-LDL-cholesterolemia in both sexes and hypercholesterolemia in men but lower risk for hypo-HDL-cholesterolemia in both sexes.

Abstract LB-339: Cause of death in cancer survivors

Abstract Background: Cancer, in general, is regarded as one of the most life threatening diseases. In the past decade, with the application of advanced scientific and medical technologies for cancer early detection, prevention, and treatment, cancer survivors are now living much longer and do not died directly from cancer, but from other diseases and complications, therefore, becomes increasingly important to understand major causes of death among cancer survivors to improve the quality of life and prolong life expectancy of cancer survivors. We conducted a study to investigate the cause of death among cancer survivors using data from national surveys. Methods: The analytical population consist of 1807 cancer survivors identified from the National Health and Nutrition Examination Survey (NHANES) III 1988-1994 and NHANES 1999- 2004. We excluded participants with age less than 18 years old and those with skin cancer. Cancer survivors were identified if they self-reported having ever been told by a doctor or other health professional that he/she had cancer or a malignancy of any kind. The cause of death was ascertained through the National Death Index (NDI). All participants were followed from the date of survey to the date of the survey to December 31, 2006 by linking NDI death certificate records. Results: The Follow-up time ranged from 0 to 17.3 years. Total 776 participants died during the follow-up period. Underlying cause of death were recoded as 113 death causes in the National Death Index. We classified all death causes into 3 categories: related with cancer, indeterminate and not related with cancer. The causes of death were stratified by the duration since the diagnosis of cancer, which was calculated as follow-up time plus years between age at NHANES survey and age when being diagnosed with cancer. Commonly reported types of cancer were prostate (n=165), breast (n=141) and colorectal cancer (n=117) among 761 male and 1046 female participants. At time of the survey, there were 17.7% and 26.5% with diabetes, 63.2 and 66.9 with cardiovascular condition, and 58.7 and 62.9 had hypertension, and 61.3% and 70.5% with hypercholesterolemia in men and women, respectively. Among the deseeded cancer survivor, 41.8%, 9.3, and 48.9% were died from cancer, indeterminate, disease not related with cancer. The percentages were 43.4%, 6.2% and 50.4%, respectively in men and 40.4%, 12.1% and 47.6%, respectively in women. Noticeably, with the increase of the duration since diagnosis of cancer, higher percentage of cancer survivor died from disease not related to cancer, ranging from 23.3% within 5 years to 72.1% in more than 30 years (p value for trend &amp;lt;0.001). Conclusion: Although cancer is the major cause of death among cancer survivors, approximately half of participants died from other diseases and complications, such as cardiovascular and respiratory diseases. Clinicians and cancer survivors should pay attention to the prevention and treatment of other diseases and complications. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-339. doi:1538-7445.AM2012-LB-339

Cut-off points of waist circumference and body mass index for detecting diabetes, hypercholesterolemia and hypertension according to National Non-Communicable Disease Risk Factors Surveillance in Iran.

IntroductionThe cut-off points of waist circumference and body mass index (BMI) are varied according to different races. There is a dearth of information on these indices especially in Iranian adults. We sought to estimate the cut-off points of waist circumference and BMI for detecting diabetes, hypercholesterolemia, and hypertension.Material and methodsThe data were gathered by the First Iranian Non-Communicable Disease Survey in 2005. In total, 70,981 participants between 25 and 64 years of old were selected via random multistage cluster sampling. Receiver operating characteristic curves were used to show the cut-off points of waist circumference and BMI for detecting diabetes, hypercholesterolemia, and hypertension. The maximum value the sum of sensitivity and specificity indicated the cut-off point.ResultsThe cut-off points of waist circumference according to maximum sum of sensitivity and specificity for detecting hypertension, diabetes, and hypercholesterolemia in men were 89.7 cm, 89.4 cm and 88.2 cm and in women were 93.9 cm, 96.2 cm and 90 cm respectively. The cut-off points of BMI according to maximum sum of sensitivity and specificity for detecting hypertension, diabetes, and hypercholesterolemia in men were 25.7 kg/m2, 24.8 kg/m2 and 24 kg/m2 and in women were 26.9 kg/m2, 26.3 kg/m2 and 26.1 kg/m2 respectively.ConclusionsThis was a population-based study on a huge sample on the basis of a national survey. The Iranian BMI was different from the values suggested by the WHO. The waist circumference in Iranian women was higher than that in men.

Sleep duration and hypercholesterolaemia: Results from the National Health Interview Survey 2008

Previous studies have shown an inconsistent association between sleep duration and hypercholesterolaemia. This study examined the association between sleep duration and hypercholesterolaemia in a nationally representative sample of US adults. A cross-sectional study of 16,652 participants in the 2008 National Health Interview Survey (aged ⩾18years, 52.5% women) was conducted. Sleep duration was categorized as ⩽5, 6, 7, 8, or ⩾9h. Hypercholesterolaemia (n=5578) was assessed by questionnaire. A significant gender difference was found in the association between sleep duration and hypercholesterolaemia (P interaction=0.003). Among women, sleep duration ⩽5h was positively associated with hypercholesterolaemia after adjusting for potential confounders and mediators including physical activity, psychological distress, body mass index, diabetes mellitus, and hypertension. Compared with a sleep duration of 7h (referent), the multivariate odds ratio (OR) of hypercholesterolaemia was 1.27 (95% confidence interval [CI] 1.04-1.54) for sleep duration ⩽5h. In contrast, among men, sleep duration ⩾8h was inversely associated with hypercholesterolaemia. Compared with a sleep duration of 7h (referent), the multivariate OR of hypercholesterolaemia was 0.80 (95% CI 0.69-0.94) and 0.78 (95% CI 0.60-1.00) for sleep durations of 8 and ⩾9h, respectively. In subgroup analyses, the positive association between sleep duration ⩽5h and hypercholesterolaemia in women, and the inverse association between sleep duration ⩾8h and hypercholesterolaemia in men, were more pronounced among those aged <60 years and race/ethnic groups other than non-Hispanic Whites. Sleep duration ⩽5h was positively associated with hypercholesterolaemia in women, whereas sleep duration ⩾8h was inversely associated with hypercholesterolaemia in men.

Clustering of Negative Affectivity and Social Inhibition in the Community: Prevalence of Type D Personality as a Cardiovascular Risk Marker

To explore the prevalence of Type D personality-the combination of negative affectivity and social inhibition-in the general population and its relationship to other cardiovascular risk factors, including psychopathological symptoms. Type D personality has been identified as a prognostic risk factor for various cardiovascular disease conditions. In a representative sample of 2698 individuals (aged 35-74 years), psychological, lifestyle, and somatic risk factors were investigated with laboratory testing, self-report measures, and a clinical interview. Type D was assessed with the German Type D Scale-14. The prevalence of Type D was 23.4% (95% confidence interval [CI], 21.2-25.6) in men and 26.9% (95% CI, 23.7-30.1) in women and, thus, in the range of classical risk factors (e.g., hypercholesterolemia). In age-adjusted analysis, Type D was associated with psychopathological symptoms, including depression and somatic symptom burden. With the exception of physical inactivity in both sexes, hypertension in women and hypercholesterolemia in men, Type D was not associated with classical cardiovascular risk factors. Multivariate analysis revealed depression, exhaustion, anxiety, and low self-rated health as associated with Type D in both sexes (odds ratios, 1.97-3.21 in men, 1.52-2.44 in women). A Type D personality disposition can be found in about a quarter of the general population, which is comparable to the prevalence of classical cardiovascular risk factors. In both sexes, an independent association to Type D appeared mainly in psychopathological symptoms. Type D constitutes a relevant and independent risk marker in the community and should receive attention in clinical practice.

The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women

BackgroundCommon genetic variants in the PCSK9 gene have been reported to be associated with both elevated and exceptionally low LDL levels. The association of a common haplotype, encompassing the E670G single nucleotide polymorphism, with LDL levels reported by Chen et al (J Am Coll Cardiol 2005; 45: 1644) was not confirmed by Kotowski et al (Am J Hum Genet 2006; 78:410–422).MethodsThe incidence of the E670G SNP was determined in 506 patients attending the lipid clinic, University Hospital, Hamburg.ResultsThe frequency in men with polygenic hypercholesterolemia, 0.11 was significantly higher than in men with LDL<50th percentile, 0.03, p = 0.01. In women there was no difference in the allele frequencies between the two groups.ConclusionIn a European population the E670G SNP in the PCSK9 gene is associated with increased LDL in men but not in women.

Lipid‐lowering effects of the squalene epoxidase inhibitor FR194738 in dogs, hamsters, and rats

AbstractSqualene epoxidase is a microsomal enzyme that catalyzes the conversion of squalene to 2,3‐oxidosqualene and is an important control site in the cholesterol synthetic pathway. FR194738 is a potent inhibitor of hepatic squalene epoxidase from dogs, hamsters, and rats with IC50 values of 49, 14, and 68 nM, respectively. In dogs, FR194738 at 10 and 32 mg/kg/day decreased serum total cholesterol levels by 26% and 40%, and serum triglyceride levels by 47% and 76%, respectively. Pravastatin, an inhibitor of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase, at 3.2 and 10 mg/kg/day also decreased serum total cholesterol levels by 32% and 36%, and serum triglyceride levels by 56% and 50%, respectively. Both FR194738 and pravastatin preferentially decreased low‐density lipoprotein cholesterol levels among the lipoprotein fractions examined. In hamsters, FR194738 decreased serum total cholesterol levels by 22% and led to a decrease in serum triglyceride levels of 9% at 100 mg/kg/day, whereas pravastatin did not decrease total serum cholesterol levels up to 100 mg/kg/day even though it decreased serum triglyceride levels at doses as low as 3.2 mg/kg/day. In rats, both FR194738 and pravastatin failed to decrease total serum cholesterol levels up to 100 mg/kg/day. FR194738 dose‐dependently decreased serum triglyceride levels by 30%, 41%, and 65% at 10, 32, and 100 mg/kg/day, respectively, whereas pravastatin decreased them only by 19% at 100 mg/kg/day. These results clearly showed a species difference in cholesterol and triglyceride metabolism, and suggest that dogs are the most appropriate animal model for evaluating hypocholesterolemic drugs. FR194738 that induced comparable effects with pravastatin in the dog model may provide another treatment for hypercholesterolemia in men. Drug Dev. Res. 54:202–208, 2001. © 2002 Wiley‐Liss, Inc.